CART22-65s
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CART22-65s, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Co-administration of CART22-65s and huCART19 for B-ALL [Phase 1, Phase 2]